BioWorld

Nov. 15, 2002

Untraditional Immune Complex Of CD137 Target, Agonistic Antibody Keep Lupus Murine Models Living

Arena, Lilly Ending GPCR Deal Early After Generating Targets

Advisory Panel Unanimously Backs Roche's HCV Therapy

Scynexis, Roche Collaborate To Discover, Develop Drugs

Other News To Note

Celgene Buying Anthrogenesis For $45M, Expanding Portfolio

Celgene Corp. is shelling out $45 million in stock and options to acquire a subsidiary - a placental stem cell recovery company called Anthrogenesis Corp. (BioWorld Today) Read More

Neurocrine Reports Positive Data From First Phase III Insomnia Trial

Today's news in brief

BioWorld

BioWorld briefs for April 16, 2026.

MMP inhibitors divulged in Accure Therapeutics patent

BioWorld Science

Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...

News in brief

BioWorld Asia

BioWorld Asia briefs for April 14, 2026

Selective CBL-B inhibitor with improved safety profile disclosed

BioWorld Science

CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...

MSD discloses new HCN1/2 blockers

BioWorld Science

Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...